Table 1.
Description of baseline data; all data are presented as n (number) and (%)
| Characteristic | Total sample (n=43) |
| Age (years) (M (SD)) | 79.47 (5.7) |
| Sex (n (%)) | |
| Male | 22 (51.2) |
| Female | 21 (48.8) |
| BMI (M (SD)) | 27.93 (5.4) |
| ASA–PS (n (%)) | |
| 3 | 32 (74.4) |
| 4 | 11 (25.6) |
| Operative procedure (n (%)) | |
| Transapicale TAVI | 11 (25.6) |
| Transfemorale TAVI | 32 (74.4) |
| Relevant comorbidities (n (%)) | |
| Hypertension | 37 (86) |
| Diabetes | 16 (37.2) |
| Congestive heart failure | 36 (83.7) |
| Congestive kidney failure | 20 (46.5) |
| Coronary heart disease | 31 (72.1) |
| Cardiac arrhythmias | 25 (58.1) |
| Stroke | 8 (18.6) |
| Nicotine | 19 (44.2) |
| Alcohol | 8 (18.6) |
| Hypothyreosis | 10 (23.3) |
| Hypercholesterinemia | 14 (32.6) |
| EuroSCORE (n (%)) | |
| Low | 15 (34.9) |
| Middle | 18 (41.9) |
| High | 10 (23.3) |
| Pre-operative anticholinergic drugs | 16 (37.2) |
ASA, American Society of Anaesthesiologists Classification; BMI, body mass index; TAVI, transcatheter aortic valve implantation.